Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of dexlansoprazole in pediatric subjects with symptomatic gastroesophageal reflux disease; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexlansoprazole (Dexilant) (Dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 1 | Status: COMPLETED | Results posted: 2012-04-05